TCP Venture Capital, which manages the Propel Baltimore Funds I and II and the Veterans' Opportunity Fund, is pleased to announce its Propel II investment into emocha Mobile Health Inc. , a leader in mobile health for providers and payers to improve public health outcomes and reduce the high cost of medication non-adherence. With proven success within pharmaceutical organizations, managed care organizations and public health departments, emocha demonstrates the important and cost-effective role mobile technology increasingly plays in managing complex and high-cost care situations.
Chris College, Managing Partner at TCP Venture Capital remarked, "Not only do we invest in scalable technology opportunities, we also invest in the talent to turn a start-up company into a sustainable organization that will return shareholder value and bring growth to Baltimore City. emocha CEO Sebastian Seiguer has demonstrated the talent to bring a concept to reality. We first met Sebastian over three years ago when emocha was too early for us to consider for an investment. To his credit, he stayed focused, put together an impressive team, and boot-strapped emocha to its current growth stage that has proven commercial acceptance and quantifiable outcomes.”
About emocha Mobile Health
emocha is on a mission to solve nonadherence in public health. Our adherence platform radically improves the way patients take medication and engage with their providers.
About TCP Venture Capital
TCP Venture Capital (www.tcp.vc) is a Baltimore, Maryland-based early-stage technology focused venture capital firm. We partner with entrepreneurs to build great businesses. The Propel Baltimore Funds makes investments in early-stage technology companies willing to locate in Baltimore City. The Fund addresses the critical need for more early-stage capital in Baltimore City, encourages more entrepreneurial activity in the City, creates more high-paying jobs, and helps to realize Baltimore City’s full potential as a destination for growing businesses.